Neurovative Diagnostics

Executive Summary

Neurovative Diagnostics is a Boston-based diagnostics service provider that offers remote, continuous video EEG monitoring through a cloud-based platform. By enabling real-time EEG data and video analysis in patients' homes or healthcare facilities, the company facilitates rapid intervention for neurological conditions such as epilepsy. Its service targets neurologists, epileptologists, hospitals, and clinical trial sponsors, aiming to improve patient outcomes and reduce operational burdens. Founded in 2016, the company leverages a differentiated model that combines convenience with clinical-grade monitoring, positioning it as a scalable solution in the growing remote patient monitoring market. The increasing prevalence of neurological disorders and the shift toward home-based care present a significant market opportunity for Neurovative Diagnostics. Its cloud-based approach offers a competitive advantage through scalability and real-time analytics, though the company faces competition from traditional EEG providers and emerging digital health platforms. As a private company with limited disclosed funding, its growth trajectory hinges on strategic partnerships and adoption by large healthcare systems. The outlook is positive but contingent on execution, making it a moderately attractive investment opportunity.

Upcoming Catalysts (preview)

• Q4 2026Commerical partnership with a major hospital network60% success
• Q1 2027Expansion into clinical trial services for epilepsy drugs50% success
• Q2 2027Series A funding announcement70% success